Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $527.60 ($4.4M) on 2026-07-16, disclosed to the SEC on 2026-07-16.
Scheduled sale ($4.4M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $527.60 | 600 | $317K | 7.1% |
| 2 | $529.81 | 120 | $64K | 1.4% |
| 3 | $531.97 | 861 | $458K | 10.3% |
| 4 | $532.94 | 800 | $426K | 9.6% |
| 5 | $534.21 | 3,279 | $1.8M | 39.5% |
| 6 | $534.99 | 1,519 |
| $813K |
| 18.3% |
| 7 | $535.88 | 1,041 | $558K | 12.6% |
| 8 | $536.85 | 80 | $43K | 1.0% |
| Total | $533.69 avg | 8,300 | $4.4M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-18 | $4.1M | — | Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |